Relugolix
- Introduction
- newest products
Introduction
Relugolix
Relugolix is a highly selective, oral, nonpeptide GnRH antagonist being investigated as a possible prostate cancer treatment.
newest products
| Image | Part # | Description | manufacturer | Stock | RFQ | |
|---|---|---|---|---|---|---|
|
|
Relugolix (737789-87-6) |
CAS: 737789-87-6; anti-tumor ; relugolix prostate cancer; relugolix injection
|
|
In Stock
|
|
